An observational study in Hypertension, sponsored by China Cardiovascular Association. Status unknown at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-11-25.
Sponsored by China Cardiovascular Association · Observational
This is a multi-center, prospective cohort study that collects only diagnostic and therapeutic data in subjects but does not interfere with treatment.
The study aims to assess blood pressure and lipid levels, the use of lipid-lowering and antihypertensive drugs, and treatment compliance and adverse events in hypertensive outpatients of 30 hospitals of different levels, following them up for 1 and 3 months after treatment, respectively. The study would reveal the compliance of blood pressure and lipid levels in hypertensive patients under management of hospitals at different levels, and analyze factors affecting blood pressure or lipid levels associated with treatment compliance. Therefore, the study would provide clinical data from the real world for future prevention and control of CVD in China.
6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.
This study's planned enrollment of 1,800 is above the median of 210 across 1,359 observational studies indexed under Hypertension.
Browse Hypertension studies →China Cardiovascular Association is the lead sponsor of 6 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Initial diagnosis of primary hypertension
Patients meeting the following criteria will be included:
Exclusion Criteria:
Patients meeting the following criteria will be excluded:
The primary endpoint will be compliance of blood pressure in hypertensive patients after 3 months of treatment in hospitals at different levels.
Blood pressure measurement: Blood pressure in both upper arms will be measured with a sphygmomanometer, with the patient in the sitting position. The mean value of three tests will be used for statistics. When left and right upper arms show different blood pressures, the higher value will be used for statistics.
Time frame: 3 months
Percentage of outpatients with abnormal blood lipid levels in hospitals at different levels
On a CardioChek dry-type biochemical analyzer, the levels of total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) in fingertip blood samples will be measured after 12-h fasting
Time frame: 3 months
Achievement rate of blood lipid levels in hypertensive and dyslipidemic patients after 3 months of treatment in hospitals at different levels
Achievement rate of blood lipid levels in hypertensive and dyslipidemic patients after 3 months of treatment in hospitals at different levels
Time frame: 3 months
Compliance of patients towards antihypertensive and lipid-lowering treatments in hospitals at different levels
Compliance of patients towards antihypertensive and lipid-lowering treatments in hospitals at different levels
Time frame: 3 months
Factors affecting blood pressure and lipid compliance in different hospitals, such as patient adverse events
Factors affecting blood pressure and lipid compliance in different hospitals, such as patient adverse events
Time frame: 3 months
Achievement rate of blood pressure in hypertensive patients under different levels of hospital management after 1 month of treatment
Achievement rate of blood pressure in hypertensive patients under different levels of hospital management after 1 month of treatment
Time frame: 1 months
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
China Cardiovascular Association